4.6 Article

Novel Serial Positive Enrichment Technology Enables Clinical Multiparameter Cell Sorting

期刊

PLOS ONE
卷 7, 期 4, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0035798

关键词

-

资金

  1. National Institutes of Health (NIH) [CA18029]
  2. German Federal Ministry of Education and Research in the framework of the Leading-Edge Cluster m4 Munich
  3. [SFB 576 (TP-A8)]
  4. [SFB 456 (TP-B13)]
  5. [TR-SFB 36 (TP-B10/13)]

向作者/读者索取更多资源

A general obstacle for clinical cell preparations is limited purity, which causes variability in the quality and potency of cell products and might be responsible for negative side effects due to unwanted contaminants. Highly pure populations can be obtained best using positive selection techniques. However, in many cases target cell populations need to be segregated from other cells by combinations of multiple markers, which is still difficult to achieve - especially for clinical cell products. Therefore, we have generated low-affinity antibody-derived Fab-fragments, which stain like parental antibodies when multimerized via Strep-tag and Strep-Tactin, but can subsequently be removed entirely from the target cell population. Such reagents can be generated for virtually any antigen and can be used for sequential positive enrichment steps via paramagnetic beads. First protocols for multiparameter enrichment of two clinically relevant cell populations, CD4(high)/CD25(high)/CD45RA(high) 'regulatory T cells' and CD8(high)/CD62L(high)/CD45RA(neg) 'central memory T cells', have been established to determine quality and efficacy parameters of this novel technology, which should have broad applicability for clinical cell sorting as well as basic research.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Engineering a Highly Active Sucrose Isomerase for Enhanced Product Specificity by Using a Battleship Strategy

Patrick Pilak, Andre Schiefner, Judith Seiboth, Johannes Oehrlein, Arne Skerra

CHEMBIOCHEM (2020)

Article Biochemistry & Molecular Biology

Design of a surrogate Anticalin protein directed againstCD98hcfor preclinical studies in mice

Friedrich-Christian Deuschle, Andre Schiefner, Corinna Brandt, Arne Skerra

PROTEIN SCIENCE (2020)

Article Biochemical Research Methods

Proline/alanine-rich sequence (PAS) polypeptides as an alternative to PEG precipitants for protein crystallization

Andre Schiefner, Rebecca Walser, Michaela Gebauer, Arne Skerra

ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2020)

Review Biotechnology & Applied Microbiology

Anticalin® proteins: from bench to bedside

Friedrich-Christian Deuschle, Elena Ilyukhina, Arne Skerra

Summary: Anticalin proteins are engineered versions of lipocalins that form a new class of clinical-stage biopharmaceuticals. Through combinatorial gene libraries and molecular selection techniques, the natural ligand specificities of lipocalins have been expanded from small molecules to peptides and proteins, leading to the development of promising Anticalin lead candidates in various disease areas. Anticalins offer an alternative to antibodies with potentially superior features as next-generation biologics, with examples of drug candidates under preclinical and clinical development.

EXPERT OPINION ON BIOLOGICAL THERAPY (2021)

Article Hematology

Complement inhibition at the level of C3 or C5: mechanistic reasons for ongoing terminal pathway activity

Marco Mannes, Arthur Dopler, Oliver Zolk, Sophia J. Lang, Rebecca Halbgebauer, Britta Hoechsmann, Arne Skerra, Christian K. Braun, Markus Huber-Lang, Hubert Schrezenmeier, Christoph Q. Schmidt

Summary: Use of C5 inhibitor eculizumab to block the terminal complement pathway has revolutionized clinical management of complement-mediated diseases. New findings show that C3/C5 convertases function differently than previously thought, with C3 inhibition not necessarily leading to C5 inhibition. Surface-deposited C4b alone can recruit and activate C5, and only C5 bound on C3b/C4b-decorated surfaces requires surface fixation for activation.
Article Biochemistry & Molecular Biology

PASylated Thymosin α1: A Long-Acting Immunostimulatory Peptide for Applications in Oncology and Virology

Uli Binder, Arne Skerra

Summary: This study successfully developed a long-acting version of Tα1, which effectively improves its plasma half-life in vivo, laying the foundation for the therapeutic development of the next generation of thymosin alpha 1. By combining PASylation technology with RimJ enzyme-mediated N-acetylation, the problems of stability, protein degradation, and low bioactivity of synthetic peptide drugs were addressed.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

The extracellular region of bovine milk butyrophilin exhibits closer structural similarity to human myelin oligodendrocyte glycoprotein than to immunological BTN family receptors

Andreas Eichinger, Irmgard Neumaier, Arne Skerra

Summary: Bovine butyrophilin (BTN1A1) is a glycoprotein found on milk fat globules that acts as a hydrophilic coat protein. Its structure differs from human immune receptors but shows similarity to human myelin oligodendrocyte glycoprotein. This discovery may provide insights into the correlation between neurological autoimmune diseases and cow milk consumption.

BIOLOGICAL CHEMISTRY (2021)

Article Oncology

Hsp70 in Liquid Biopsies-A Tumor-Specific Biomarker for Detection and Response Monitoring in Cancer

Caroline Werner, Stefan Stangl, Lukas Salvermoser, Melissa Schwab, Maxim Shevtsov, Alexia Xanthopoulos, Fei Wang, Ali Bashiri Dezfouli, Dennis Tholke, Christian Ostheimer, Daniel Medenwald, Martin Windberg, Matthias Bache, Martin Schlapschy, Arne Skerra, Gabriele Multhoff

Summary: Tumor-specific biomarkers, such as Hsp70 in liquid biopsies, are useful for tumor detection, monitoring of responses, and outcome prediction. The compHsp70 ELISA, using two monoclonal antibodies, is a sensitive and reliable tool for measuring free and vesicular Hsp70 levels in tumor patients' circulation, serving as a potential biomarker for risk assessment and therapeutic monitoring.

CANCERS (2021)

Article Chemistry, Multidisciplinary

Direct Affinity Purification of Long-Acting PASylated Proteins with Therapeutic Potential Using L-Prolinamide for Mild Elution

Jonas Schilz, Charlotte Clement, Franziska Greiner, Arne Skerra

Summary: A novel strategy for the efficient and gentle affinity purification of PASylated proteins is reported, which allows direct one-step purification from cell extracts or culture supernatants while avoiding harsh elution conditions. This method can improve the efficiency of biological drug development.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)

Article Biochemistry & Molecular Biology

Structural basis of Alzheimer beta-amyloid peptide recognition by engineered lipocalin proteins with aggregation-blocking activity

Andreas Eichinger, Sabine Rauth, Dominik Hinz, Anna Feuerbach, Arne Skerra

Summary: In this study, the structural analysis of two Anticalin(R) proteins that tightly bind A beta(40) peptide, a key player in Alzheimer's disease, were described. These proteins, engineered based on human lipocalin 2, show compact single-domain binding properties and offer a potential alternative to antibodies. Both crystal structures of the engineered anticalins revealed their ability to recognize the same epitope in the middle of the beta-amyloid peptide. This finding suggests that anticalins may play a significant role in the pathophysiology of Alzheimer's disease.

BIOLOGICAL CHEMISTRY (2022)

Article Gastroenterology & Hepatology

Metabotropic 5-HT receptor-mediated effects in the human submucous plexus

Anita Annahazi, Thomas Erwin Berger, Ihsan Ekin Demir, Florian Zeller, Michael Muller, Markus Anneser, Arne Skerra, Klaus Michel, Michael Schemann

Summary: This study demonstrated for the first time the presence of functional 5-HT1P receptors on human submucous neurons and found no evidence for a role of 5-HT4 or 5-HT7 receptors in the postsynaptic activation of human submucous neurons by 5-HT.

NEUROGASTROENTEROLOGY AND MOTILITY (2022)

Article Biochemistry & Molecular Biology

Structural and Functional Analysis of a Highly Active Designed Phosphotriesterase for the Detoxification of Organophosphate Nerve Agents Reveals an Unpredicted Conformation of the Active Site Loop

Laura Job, Anja Kohler, Andreas Eichinger, Mauricio Testanera, Benjamin Escher, Franz Worek, Arne Skerra

Summary: Neurotoxic organophosphorus compounds (OPs) can be extremely dangerous when misused. A potential treatment involves using an enzyme to break down the nerve agent into harmless substances. The bacterium Brevundimonas diminuta (BdPTE) has been studied for its potential in this area. Engineering studies have led to improved versions of BdPTE with high catalytic efficiency. Unexpectedly, the crystal structure of a highly active variant revealed a new conformation in the active site region, leading to further amino acid exchanges and optimization of the enzyme for OP nerve agent detoxification.

BIOCHEMISTRY (2023)

Article Biochemistry & Molecular Biology

FerryCalin: an Engineered Lipocalin Protein Directed against the Transferrin Receptor with Potential for Brain Drug Delivery

Lea Naestle, Friedrich-Christian Deuschle, Volker Morath, Arne Skerra

Summary: The transferrin receptor (TfR) plays a role in transporting substances across the blood-brain barrier, offering a non-invasive way to deliver therapeutics to the brain. Researchers have identified a specific lipocalin, called FerryCalin, which binds to murine TfR and shows potential as a vehicle for delivering biopharmaceuticals to the brain. Through affinity maturation, lipocalin variants were engineered to bind to TfR in a non-competitive manner, with FerryCalin exhibiting a dissociation constant of 3.8 nM. This research provides insight into the potential use of FerryCalin or its mutants for brain drug delivery.

CHEMBIOCHEM (2023)

Article Biochemical Research Methods

Drastic alterations in the loop structure around colchicine upon complex formation with an engineered lipocalin indicate a conformational selection mechanism

Elena Jerschke, Andreas Eichinger, Arne Skerra

Summary: Using Anticalin technology, a lipocalin protein named Colchicalin has been engineered with high affinity for the toxic plant alkaloid colchicine, offering potential as an antidote and for sensitive detection in biological samples. The crystal structure of unliganded Colchicalin and its complex with colchicine were compared, revealing significant rearrangements in four structurally variable loops. Upon binding to colchicine, a dramatic shift and side-chain flip occur in loop #3 and Phe71, respectively, creating space in the ligand pocket. These findings demonstrate a conformational adaptation mechanism similar to that observed in antibodies, highlighting the general similarity between antigen/ligand binding by immunoglobulins and lipocalins.

ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2023)

Article Biochemistry & Molecular Biology

Engineering of a phosphotriesterase with improved stability and enhanced activity for detoxification of the pesticide metabolite malaoxon

Laura Job, Anja Koehler, Mauricio Testanera, Benjamin Escher, Franz Worek, Arne Skerra

Summary: In this study, the phosphotriesterase of Brevundimonas diminuta (BdPTE) was rationally engineered to improve its hydrolysis efficiency of malaoxon, a common pesticide metabolite. The mutant BdPTE(VRNVVLARY) showed significantly increased hydrolysis rate and improved properties including expression yield, thermal stability, and oxidation resistance. This mutant BdPTE could be a promising candidate for developing a biocatalytic antidote for the detoxification of common pesticides and related organophosphorus compounds.

PROTEIN ENGINEERING DESIGN & SELECTION (2023)

暂无数据